Skip to content
Parker Institute for Cancer Immunotherapy
Search Close


A Q&A with the Founders of ArsenalBio

Sometimes different ingredients come together to make something so much greater than the sum of its parts, with a deep scientific impact that has the potential to deliver improved cell therapies for cancer patients.

That’s the case for Arsenal Biosciences, a company whose scientific founders – members of the PICI Network – began with their own ideas on how to overcome the challenges of treating solid tumors. But as they began to work together, they realized they each brought something to the table that could solve a different part of the equation. In addition to investing in the company, PICI also helped the founders refine the vision of what ArsenalBio could be.

Learn more about ArsenalBio’s origins and its plans to impact the lives of patients.